USPTO serial 85400188
O
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- JUN, WON KYUNG WENDY
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with O?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
81477 Munchen, DE
81477 Munchen, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
John Christopher
JOHN CHRISTOPHER CHRISTOPHER & WEISBERG, P.A.200 E LAS OLAS BLVD STE 2040FORT LAUDERDALE, FL 33301-2240UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preparations, namely, buffers, polypeptides, nucleic acids for scientific research purposes, water-oil solutions, chemical preparations in the form of powders, chemical preparations in the form of ointments, lyophilisates, dispersion solutions, emulsions, suspensions, liposomes, and chemical additives, all for scientific research purposes; chemical agents, namely, polypeptides, nucleic acids for characterizing and examination of animal and human diseases, eukaryotic cells, eukaryotic cell culture lines, microorganisms, nucleic acids, polypeptides, animal and human material in the nature of cells out of cell culture, of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples prepared with a laser, of cells isolated with Flourescence Activated Cell Sorting devices FACS or with receptor/ligand binding, of cells of chemically fixed tissue, of micrometastatic cells, of bone marrow cells, of samples from body fluids, of stem cells, cloned single cells or differentiated stages from specific cells, all for scientific research purposes; eukaryotic cells, eukaryotic cell culture lines, microorganisms, nucleic acids, polypeptides, animal and human material in the nature of cells out of cell culture, of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples prepared with a laser, of cells isolated with FACS or with receptor/ligand binding, of cells of chemically fixed tissue, of micrometastatic cells, of bone marrow cells, of samples from body fluids, of stem cells, cloned single cells or differentiated stages from specific cells, all for scientific research purposes | ACTIVE | — |
| 005 | Medicaments, namely, for use in the treatment of tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, and minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases; pharmaceutical and veterinary preparations, namely, for use in the treatment of tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, and minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases, preparations for clinical diagnosis and analysis of animal and human diseases for clinical medical use; eukaryotic cells, eukaryotic cell culture lines, animal and human material in the nature of cells out of cell culture, and of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples prepared with a laser, of cells isolated with Fluorescence Activated Cell Sorting devices FACS or with receptor/ligand binding, of cells of chemically fixed tissues, of micrometastatic cells, of bone marrow cells, of samples from body fluids, of stem cells, cloned single cells or differentiated stages from specific cells, eukaryotic cells, eukaryotic cell culture lines, microorganisms, nucleic acids, polypeptides, animal and human material in the nature of cells out of cell culture, of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples prepared with a laser, of cells isolated with FACS or with receptor/ligand binding, of cells of chemically fixed tissue, of micrometastatic cells, of bone marrow cells, of samples from body fluids, of stem cells, cloned single cells or differentiated stages from specific cells, all for medical purposes, namely, for use in the treatment of tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, and minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases; sanitary preparations for medical purposes, namely, pharmaceutical agents for dental care | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 15, 2012 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 15, 2012 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 13, 2012 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 17, 2012 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 17, 2012 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 28, 2011 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 9, 2011 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 8, 2011 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Dec 8, 2011 | ALIE | ASSIGNED TO LIE | — |
| Dec 7, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 7, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 23, 2011 | MDSC | NOTICE OF DESIGN SEARCH CODE MAILED | — |
| Aug 22, 2011 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 20, 2011 | NWAP | NEW APPLICATION ENTERED | — |